It has been associated with several other potential health benefits, including reducing the risk of chronic diseases, such as cardiovascular disease, age-related macular degeneration and certain types of cancer, and may also have anti-inflammatory properties that play a role in supporting brain health
Patients should be aware that the pharmacological profile of triple agonist therapies is still being characterised, and a cautious approach to concurrent supplement use is reasonable
Antioxidants neutralize unstable compounds called free radicals in the body, and are vitally important for the function of a healthy immune system, lowering the risk of chronic disease, and slowing down the aging process
The Role of GLP-1 Agonists in Perimenopausal Weight Management Appetite Suppression GLP-1 agonists, such as semaglutide (Wegovy) and Tirzepatide (Mounjaro), are known for their ability to suppress appetite and reduce food cravings, which can be particularly beneficial for women experiencing weight gain during perimenopause
For a broader look at energy changes across this medication class, see our article on does GLP-1 make you tired
Our team monitors your progress throughout your treatment to ensure that any side effects are addressed quickly
